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ABSTRACT 
Infections contribute to the development of more than 20% of all malignancies in humans. 
While strong evidence exists for a number of virus-associated cancers, the role of bacterial 
infections is still poorly appreciated although there are evidences that link chronic bacterial 
infections to increased risk of certain tumors. In the context of bacteria-induced 
carcinogenesis, bacterial genotoxins might contribute to increase the occurrence of genomic 
instability during chronic infection. These toxins are produced by several Gram-negative 
bacteria and are unique among other bacterial toxins since they are able to reach the nucleus 
and cause DNA damage in intoxicated cells.  
In this thesis we have investigated the contribution of two bacterial genotoxins to tumor 
development in acute and chronic intoxication, and their role in the context of chronic 
infections, using in vivo and in vitro models. We have used as a model the Cytolethal 
Distending Toxin (CDT) produced by several Gram-negative bacteria and the Typhoid Toxin 
(TT) produced by Salmonella enterica serovar Typhi. 
In the context of acute intoxication, CDT-induced DNA damage triggers the activation of the 
integrin β1, increase of focal adhesions formation and cell spreading in epithelial cells during 
short-term intoxication experiments (Paper I). This phenotype is mediated by an inside-out 
integrin signaling and is drastically reduced when the actin cytoskeleton remodeler NET1 is 
knocked down.  We have also demonstrated that two components of the endosomal sorting 
complex required for transport (ESCRT) known to regulate integrin intracellular trafficking, 
ALIX and TSG101, are important for the anchorage-independent survival induced by sustain 
integrin activation.  
Chronic intoxication with CDT leads to increased mutation frequency, accumulation of 
chromosomal aberrations and enhanced anchorage-independent growth in vitro (PaperII). 
Cells treated with sub-lethal doses of CDT during a period of 220 days showed an altered 
DNA damage response and a higher activation of the MAP kinase p38 signalling, which is 
known to play an important role in cell survival during acute CDT intoxication.  
In order to investigate the role of genotoxins in vivo and their carcinogenic potential we 
designed a new Salmonella infection model in mice where we used a S. enterica serovar 
Typhimurium (S. Typhimurium) strain able to produce the Typhoid Toxin and, as a control, 
an isogenic strain that expressed an inactive Typhoid Toxin (PaperIII). We have infected 
immunocompetent sv129 mice for up to 6 months and the presence of an active version of the 
toxin led to a reduced mortality rate and higher persistence of the bacteria in some organs 
suggesting its role in the establishment of a chronic infection. Mice infected with the 
toxigenic S. Typhimurium strain also showed an altered inflammatory response in intestine 
and liver and a more pronounced intestinal microbiota alteration compare to the mice infected 
with the non-toxigenic strain.  
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To better understand how the TT is delivered to the host cells we further investigate its 
secretion and internalization mechanisms in vitro (Paper IV). We have demonstrated that the 
Typhoid Toxin is loaded into outer membrane vesicles (OMVs) and is secreted by S. 
Typhimurium bacteria in the Salmonella containing vacuole (SCV). Vesicles are released by 
exocytosis-like process in the extracellular space, where they can deliver the genotoxic 
component to bystander cells.  
Our data give new important contributions in the studying of bacterial genotoxins and their 
role in chronic bacterial infection and cancer development.   
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AIMS OF THE THESIS 
Bacteria can be associated with cancer development but the mechanisms by which this occurs 
are still unknown. We have investigated whether bacteria-producing DNA damage agents can 
contribute to carcinogenesis by looking at different aspects: 
1. Characterization of the CDT-induced survival responses (Paper I) 
2. Assessment of the carcinogenic potential of CDT in vitro (PaperII) 
3. Characterization of the role of the Typhoid Toxin in the context of Salmonella 
chronic infection in vivo (PaperIII) 
4. Characterization of the Typhoid Toxin secretion and delivery pathways in vitro 
(PaperIV) 
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1 BACTERIA AND CANCER 
 
Historically several bacteria have been putatively associated to cancer development. Already 
in the 1772, Mycobacterium tuberculosis was thought to be the cause of bronchogenic 
carcinomas 1 even though it is still not clear today if there is or not an effective link between 
tuberculosis and cancer. A wide variety of studies on bacteria associated with carcinogenesis 
are under way and this is an up-to-date research area with many points to be clarified. 
Helicobacteri pylori, Salmonella Typhi, Streptococcus bovis and Chlamydia pneumoniae are 
associated with different types of cancer such as gastric cancer, mucosa associated lymphoid 
tissue (MALT) lymphoma, gallbladder cancer, colorectal cancer and lung cancer respectively 
2-6. Although there are many evidences on the connection between these bacteria and cancer 
development, their possible role in carcinogenesis is still not completely clarified. 
 
H. pylori and cancer 
The major bacterial cause of human cancer today is H. pylori, which was classified as being 
carcinogenic for humans in 1994 by the WHO (World Health Organization) and linked to 
two different types of gastric cancer: MALT lymphoma and gastric adenocarcinoma 6. H. 
pylori is present in the stomachs of at least half of the world's population and, if left 
untreated, generally persists for the host life time 7,8. In developed countries, H. pylori 
probably increases the risk of developing gastric cancer by sixfold but its presence is 
sometimes difficult to detect because H. pylori colonization diminishes in the presence of 
premalignant lesions 9. One of the most important factors that characterizes H. pylori strains 
is the presence of the cag island, a horizontal acquired locus that contains 31 genes 10,11. Most 
of the genes belonging to the cag island encode for type IV secretion system (T4SS) proteins, 
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which export proteins from bacterial cells. The cytotoxin-associated gene A (CagA) is one of 
the factors transported through the T4SS into the epithelial cells, where it undergoes tyrosine 
phosphorylation 12. Once phosphorylated, CagA affects cell shape, increases cell motility, 
abrogates junctional activity, and promotes an epithelial to mesenchymal transition-like 
phenotype 13.  
Several studies demonstrated that compared with cagA- strains, H. pylori cagA+ strains 
significantly increase the risk of developing severe gastritis, atrophic gastritis, peptic ulcer 
disease and distal gastric cancer (reviewed in 7). 
 
S. Typhi and cancer 
Besides H. pylori, there are other known examples of bacterial-associated cancer 
development. One of the most important is Salmonella Typhi infection and gallbladder 
cancer in individuals who become chronic asymptomatic carriers after typhoid fever 14.  
S. Typhi is still a worldwide threat for human health and it is estimated that at least 22 million 
people worldwide suffer typhoid fever every year 15. This bacterium is endemic in many 
regions of South America, Africa, and Asia 16. Typical symptoms include fever, malaise, 
headache, nausea, and abdominal pain, which are caused by a systemic infection that can lead 
to high temperature and severe diarrhea if left untreated 17. A considerable percentage of 
infected people (2-5%) 18 becomes chronic carrier and it is still unknown why this happens 
only in some of the patients. Such individuals are considered as a reservoir of the infection 
that persists in the gallbladder and can then spread out again through the shedding of S. Typhi 
in the stools for a long period of time after the infection has taken place 19. 
Chronic carriers show an increased risk (8.47 times) of developing carcinoma of the 
gallbladder compared with people who have had acute typhoid and have cleared the infection 
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3. In a recent study by Scanu and colleagues it has been shown that S. Typhi DNA can be 
detected in gall bladder carcinoma (GBC) samples from Indian patients while no trace of the 
bacterium is found in samples coming from the Netherlands. Although S. Typhi DNA has 
been found in most of the Indian samples, the bacterium itself is only rarely detected in the 
tumor cells suggesting that S. Typhi may induce transformation, but viable bacteria are not 
required to keep the transformation state 20.  
 
Chronic infection, inflammation and cancer 
Rather than link cancer to specific organisms, most of the research effort has been put in 
understanding the mechanisms behind the carcinogenesis induced by bacteria and this 
represents the main question in this field.  
Chronicity of infection is a crucial point in cancer-associated bacterial infection. In literature 
many studies demonstrated that there is a correlation between bacteria and cancer but an 
indisputable direct link has not been proven to date. In most of these studies it seems clear 
that bacteria are not sufficient to lead to cancer development on their own. A chronic 
inflammation is needed to start the process and an independent accumulation of mutations in 
genes involved in oncogenesis signaling pathways might be quite relevant. One such example 
is represented by Helicobacter hepaticus, which is the cause of chronic active hepatitis that 
then leads to hepatocellular carcinoma formation in A/JCr mice 21.  
More recently another interesting finding has proven the association of the gut microbiota and 
colorectal cancer.  Inflammatory bowel disease (IBD), one of the three highest risk factors 
for colorectal cancer (CRC), can occur when the homeostasis between the intestinal 
microflora and the host immune system is disrupted 22. Whether individual pathogenic 
species or entire microbial communities trigger inflammation is still unknown 23. A good in 
vivo model to study the commensal-dependent ulcerative colitis is the T-bet−/− RAG2−/− 
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ulcerative colitis (TRUC) mice that present a T-bet deficiency in the innate immune system 
24. TRUC mice develop a severe and highly penetrant colitis and spontaneously progress to 
colonic dysplasia and rectal adenocarcinoma, resembling human IBD-associated colorectal 
cancer 25. The authors have shown that tumorigenic and pre-tumorigenic lesions can be 
reduced by treatment with antibiotics, suggesting a significative role of bacterial-induced 
carcinogenesis 25.  
An enrichment of Fusobacterium species has been found in colorectal cancers adjacent to 
normal tissues even though it is not clear if these bacteria directly contribute to 
carcinogenesis 26-28. In 2013 Kostic and colleagues analyzed the effects of F. nucleatum in 
ApcMin/+ mice. They showed an increase in tumor multiplicity and a recruitment of myeloid 
cells, which can promote tumor progression 29. 
In another study Wu and colleagues showed that the enterotoxigenic Bacteroides fragilis 
(ETBF) triggers colitis and colonic tumors in multiple intestinal neoplasia (Min) mice 
(ApcMin/+) 30. 
In all the examples cited above, inflammation seems to be one of the central and most 
important connections to cancer development.  
The main question at this point is: what are the molecular players in the pro-tumourigenic 
inflammation process? 
The nuclear factor κB (NF-κB) family and the Signal Transducer and Activator of 
Transcription 3 (STAT3) are long known as important mediators in the inflammatory 
process, and also demonstrated to play a key role in inflammation-associated carcinogenesis 
31,32. 
NF-κB and STAT3 proteins are transcription factors ubiquitously expressed in the cytoplasm 
of all cells. Upon extracellular stimuli these proteins translocate to the nucleus and activate 
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transcription of important inflammatory-response genes, which encode for anti-apoptotic 
proteins, chemokines, cytokines and growth factor receptors 33.  
In absence of signals, NF-κB transcription factors are present in their inactive form bound to 
inhibitory proteins called I-κBs. In response to external stimuli such as cytokines, viral and 
bacterial products, different cellular receptors can activate NF-κB through the IκBs kinases 
(IKKs). These enzymes are composed by three subunits: catalytic subunits IKKα and 
IKKβ and the regulatory subunit IKKγ/NEMO. IKKs are able to phosphorylate IκBs leading 
to ubiquitin-dependent degradation and the subsequent nuclear entry of the released NF-κB 
dimers 34. Once in the nucleus, NF-κB can exert its activity and activate the transcription of 
different genes whose products are involved in the inhibition of apoptosis and in the 
stimulation of cell growth 35. 
Similarly to NF-κB, STAT3 is kept in an inactive form in the cytoplasm of non-stimulated 
cells but it does not require the degradation of an inhibitor 36,37. STAT3 activation depends 
instead on the phosphorylation of the tyrosine 705 (Tyr705) by the Janus Kinase (JAK) JAK1 
that leads to dimerization through phosphotyrosine-SH2 domain interaction 38,39. STAT3 
activity in the nucleus might be increased by the phosphorylation of the Ser727 by members 
of the Mitogen-Activated Protein Kinases (MAPK) and c-Jun N-terminal kinase families 40. 
Development and homeostasis are the two main mechanisms in which STAT3 is involved 
and ablation of its gene leads to developmental abnormalities and death 41. Prolonged 
activation of STAT3 is associated with different types of malignancies and its activated 
nuclear form has been found in different kind of cancers such as breast, lung, skin, colon, etc 
… 31,37,42,43.  
One of the hallmarks for cancer is represented by the ability of malignant cells to enter to an 
anti-apoptotic and prosurvival state that prevents cell death 44. Anti-apoptotic genes, such as 
Bcl-xL, Bcl-2 and c-IAP-2, are often targeted by NF-κB and STAT3 45,46. The inhibition of 
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STAT3 or NF-κB leads to an increase of p53-induced apoptosis demonstrating that these two 
factors have an important effect also on the most important tumor suppressor 47,48.  
 
Fig. 1: Scheme of the effects of acute or chronic inflammation on tissues. In normal conditions cells 
with damaged DNA undergo apoptosis and are substitute by normal cells (healthy state). During acute 
infection NF-κB and/or STAT3 are activated for a short time and DNA-damaged cells normally 
undergo to apoptosis (recovery). During chronic infection the persistent activation of NF-κB and/or 
STAT3 can lead to uncontrolled cell growth due to inhibition of apoptosis (Cancer). Adapted from 49. 
 
The molecular mechanisms by which this occurs are still under debate but what is known is 
that in acute infections the negative regulation of p53 is not carcinogenic and only a long-
term effect, as for chronic inflammation, can be associated with cancer development 50. NF-
κB or STAT3-activated/p53-suppressed state has to last for a sufficient time in order to over 
come the p53-dependent apoptosis, accumulate genetic and epigenetic alterations and lead to 
a transformed phenotype. This assumption is in line with the fact that a significant fraction of 
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cancers express a wild-type p53, which may be inactivated by other mechanisms such as a 
constant activation of STAT 3 and NF-κB. Thus inhibition of NF-κB and/or STAT3 in cancer 
cells harboring a wild-type p53 might represent a new therapeutic advantage in cancer 
treatment 48,49. On the other hand, the accumulation of mutations can be also increased by the 
production of Reactive Oxigen and Nitrogen Species (ROS and RNS), which are produced in 
high amount by inflammatory cells during chronic infections. As a result the overproduction 
of these molecules can cause oxidative and nitrative stress, which in turn can contribute to the 
damage of different biomolecules such as DNA, RNA, lipids and proteins 51. Figure 1 
summarizes the effects of acute and chronic infection induced by activation of NF-κB or 
STAT3. 
 
Bacterial genotoxins 
Besides the indirect effects of bacterial infections on the carcinogenic process via the 
induction of chronic inflammation and constitutive activation of the non-classical oncogenes 
NFκB and STAT3, and production of endogenous DNA damaging agents, several bacteria 
effectors may contribute to the tumor initiation and/or progression. These bacterial toxins are 
collectively known as cyclomodulins 52 and can either block apoptosis and promote cell 
proliferation (e.g. Cytotoxic Necrotizing Factor, CNF and Pasteurella multocida Toxin, 
PMT,  produced by Esherichia coli and Pasteurella multocida respectively ) or can induce 
DNA damage, thus directly contributing to acquisition of genomic instability. The latter are 
known as bacterial genotoxins and so far only three of them have been identified.  Two are 
protein toxins: the Cytolethal Distending Toxin (CDT) produced by several Gram-negative 
bacteria and the Typhoid Toxin produced by Salmonella Typhi 53,54. The third bacterial 
genotoxin described is called Colibactin and is a peptide-polyketide genotoxin, produced by 
strains belonging to the phylogenetic group B2 of Escherichia coli 55.  
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Cytolethal distending toxin 
The first bacterial genotoxin described is the Cytolethal Distending Toxin (CDT) family. 
Gram-negative bacteria such as Escherichia coli, Shigella dysenteriae, Aggregatibacter 
actinomycetemcomitans, Campylobacter spp., Helicobacter spp. and Haemophilus ducreyi, 
produce CDT, which causes DNA damage. Such damage induces cell cycle arrest and 
cellular distention in epithelial cells as well as apoptosis in cells of lymphoid origin. CDT is 
an AB2 toxin, composed by the CdtB active subunit (“A”), and two accessory subunits (“B”), 
CdtA and CdtC as shown in Figure 2 left panel. The genes encoding for CDT (cdtA, cdtB, 
cdtC) are transcribed from a single operon 53. The active subunit (CdtB) presents a canonical 
four layered-fold structure of the DNase I family, and it has been shown to cleave naked 
DNA in vitro and promote single and double strand breaks in intoxicated cells 56-58. Mutations 
of the CdtB catalytic domain and the Mg2+ binding site impair CDT intoxication activity 56,59. 
The two “B” subunits are lectin-type molecules, sharing structural homology with the B-
chain repeats of the plant toxin ricin 60. The crystal structure of the holotoxin shows the 
presence of a groove between the CdtA and CdtC subunits and a patch of aromatic residues 
on CdtA, adjacent to the groove. These structures may play a relevant role in modulating 
toxin binding to the cognate receptor, still unknown, on the cell surface 60.  This step is 
essential to mediate internalization of the holotoxin into the target cells 60. 
Upon binding to an unknown receptor, CDT is internalized via endocytosis and transits 
through the early and late endosomal compartments 61. Similarly to other cytosolic acting 
toxins, such as ricin, shiga and cholera toxins 62, the CdtB active subunit requires 
translocation via the endosomal compartment, transit through the Golgi complex and 
transport to the endoplasmic reticulum (ER) in order to reach their targets 63. In Figure 4 CDT 
internalization is summarized in right side of the picture.  
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Unlike other bacterial toxins, the target of CDT is nuclear, and the toxin has not been detected 
in the cytosol by biochemical assays. Furthermore, intoxication occurs in cells displaying a 
non-functional ERAD (Endoplasmic-reticulum-associated protein degradation) pathway 
suggesting that the toxin may be directly translocated from the ER to the nucleus 61,63.  The 
mechanism by which CDT is translocated from the ER to the nucleus and the cellular 
partners involved are still unknown. 
Eshraghi and colleagues have recently demonstrated that three important components of the 
ERAD machinery (Derlin-2 (Derl2), the E3 ubiquitin-protein ligase Hrd1, and the AAA 
ATPase p97) are necessary for CDT intoxication. Nevertheless two motifs required for 
Derlin-dependent retrotranslocation of ERAD substrates have been found to be dispensable 
for CDT intoxication. These data suggest that an atypical ERAD pathway might be involved 
in CDT trafficking in intoxicated cells 64. 
 
Fig. 2: Crystal structures of the Cytolethal Distending Toxin (left) and the Typhoid Toxin (right) 
Typhoid toxin 
TT is an A2B5 toxin where the A subunits, PltA and the S. Typhi CdtB (StCdtB), are 
homologues of the A subunits of the pertussis toxins and the cytolethal distending toxins, 
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respectively 54. The PltA has an ADP-ribosyl transferase activity but its cellular targets have 
not yet been identified 54 while StCdtB induced DNA damage into the target cells 65.  PltB 
represents the “B” subunit and it is organized into a pentameric structure 54,66. In Figure 2 
(right panel) is shown the crystal structure of the Typhoid Toxin. 
Although the role of TT in S. Typhi infection is still unknown, Song and colleagues showed 
that intraperitoneal injection of purified and active TT in C57BL/6 mice, leads to symptoms 
similar to the ones of acute phase of typhoid fever (loss of weight, malaise, etc.)54. The 
authors have further shown that the symptoms are exclusively induced by a functional CdtB, 
since only mutation of this subunit, but not of the other “A” subunit, PltA, promotes typhoid-
like symptoms 54.  
Interestingly the presence of the toxin seemed to affect also the immune system by strongly 
reducing the circulating neutrophils 54. 
Further studies by the same group showed that intraperitoneal injection of a mutant strain of 
S. Typhi deleted of the PltB subunit, exhibits increased replication in the liver and spleen of 
immunodeficient Rag2−/− γc−/− humanized mice 67. These data suggest that a functional TT 
may be important for the establishment of a persistent infection by slowing down the 
replication of S. Typhi in the infected tissues 67.         
Colibactin 
Colibactin is produced by E. coli strains belonging to the phylogenetic group B2 55. The 
effects of colibactin on target cells are enlargement of the cell body and the nucleus and arrest 
of cell proliferation. Interestingly these effects are contact-dependent and are not observed 
when bacteria are separated from the cells with a membrane or if cells are treated only with 
the supernatant of bacterial culture 55. Genes responsible for the production of an active 
colibactin are located on a genomic region called pks island. Nougayrede and colleagues have 
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shown that infection with pks positive bacteria induced DNA double strand breaks and a 
consequent activation of the DNA damage response in eukaryotic cells 55.  
Cuevas-Ramos and colleagues studied the effects of colibactin on DNA damage in a mouse 
intestinal loop model and in the colon of antibiotic treated BALB/cJ mice. Colon loops and 
mice were infected with an E. coli strain harboring the pks island for 6 hours and 5 days, 
respectively and an isogenic strain (clbA mutant) unable to produce a functional toxin was 
used as negative control 68. The central role of the clbA gene in colibactin biosynthesis was 
confirmed in both models and the expression of clbA was also associated with induction of 
DNA damage and consequent phosphorylation of the histone H2AX (a marker for DNA 
damage) in mouse enterocytes 68.  
 
So far I have been describing different factors that have a direct or indirect effect in damaging 
the DNA. It is important at this point to discuss more in details about the DNA damage 
response and whether genotoxins, and specifically CDT and TT, can contribute to 
carcinogenesis.  
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2 DNA DAMAGE RESPONSE 
 
The DNA is one of the most stable molecules found in nature but despite this, its integrity is 
threatened everyday by multiple factors. It has been estimated that the DNA of a single cell 
of the human body can experience between 104-105 damages per day 69. The causes of these 
damages can be exogenous (e.g. ionizing radiation (IR), radiomimetic chemicals, UV 
radiation) or endogenous (e.g. ROS, RNS, stalled replication forks, etc…) DNA damaging 
agents, which can lead to DNA double strand breaks (DSBs) or single strand breaks (SSBs), 
thymidine dimers, base oxidation, etc… 
Catastrophic consequences are avoided due to a number of mechanisms that maintain the 
genomic integrity, generation after generation. These mechanisms are part of the DNA 
Damage Response (DDR) where a set of different proteins are involved in cell cycle 
checkpoints and DNA repair.  
Bacterial genotoxins induce mainly DNA DSBs 58, thus I will review in this chapter the repair 
mechanisms that are activated in response to this type of DNA damage 
 
NHEJ or HR? 
DSBs can be repaired through at least two different pathways: homologous recombination 
(HR) or non-homologous end-joining  (NHEJ) 70-72. The choice of which repair pathway will 
be used depends essentially on the phase of the cell cycle in which the damage occurs. HR 
requires a homologous DNA template, thus it can be activated exclusively in S- and G2-
phase. Conversely, cells in G1 or G0-phase relay on NHEJ as repair process 69. The main 
difference between the two pathways is that while in the HR the DNA is repaired in an error-
free process using the sister chromatid as template, during NHEJ part of the damaged DNA is 
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resected and/or processed with consequently loss of information. HR and NHEJ pathways are 
summarized in Figure 3.  
In general DNA repair is carried out by an intricate group of pathways that involve several 
enzymes including nucleases, helicases, kinases, phosphatases, etc. The regulation of all these 
factors is crucial in order to maintain the integrity of the genome upon DNA damage and 
cells have developed different mechanisms to increase the reliability of the system 69. 
 
Fig. 3: Schematic representation of NHEJ (left panel) and HR (right panel) DNA repair systems in 
response to DSBs. 
Sensing the damage 
The first step of the DDR is the sensing of the damage, which is initially mediated by 
members of the poly(ADP-ribose) polymerase (PARP) family for the HR and by the Ku 
heterodimer (Ku70/Ku80) for the NHEJ.  
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Among the 16 members of the PARP family, only PARP 1 and PARP2 are involved in the 
DDR and, as for the Ku70/Ku80, they localize to the site of the damage within seconds 73,74. 
The role of PARP1/2 and Ku70/Ku80 is crucial for the decision of which repair pathway will 
be used (NHEJ or HR). While Ku heterodimer leads to NHEJ, PARP1/2 can activate either 
HR or an alternative version of NHEJ (alt-NHEJ). The majority of the higher eukaryotes, and 
especially mammals, generally prefer to repair DSBs through the classical NHEJ (c-NHEJ) 
and this pathway has been extensively described in different articles 75,76 where it is clear the 
intervention of at least seven different proteins: Ku70/Ku80, DNA-PK, Artemis, X-rays cross 
complementing 4 (XRCC4), XRCC4-like factor (XLF) and DNA ligase IV (LIGIV) 77. 
On the other hand the alt-NHEJ mechanism has been not yet well elucidated but it has been 
demonstrated that it is much less used compare to c-NHEJ and somehow repressed by the 
presence of Ku70/Ku80, which repress also the HR pathway 78. 
In summary even though the HR system is safer in terms of preserving the exact sequence of 
DNA, cells are more prone to use NHEJ mechanism to repair damaged DNA and this might 
be due to the fact that this alternative is much faster and efficient 79. 
 
Propagation of the signal and DNA repair 
The propagation of the signal is the second step of the DDR and starts with the recruitment 
and the activation of the DNA-dependent protein kinase (DNA-PK) by Ku70/Ku80 or the 
MRE11/RAD50/NBS1 (MRN) protein complex by PARP1/2 74. 
During NHEJ, the Artemis nuclease is recruited upon DNA-PK loading leading to resection 
of the DNA in order to generate the right 3’-hydroxyl and 5’-phosphate ends essential for 
ligase activity and DNA repair 69,70. 
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The Ataxia Telangiectasia Mutated protein (ATM) is recruited by the NBS1 subunit of the 
MRN complex during the HR leading to the propagation of the signal and DNA repair 69,70. 
Alternatively to ATM, the ATM Rad3-related (ATR) protein kinase is recruited in case of 
SSBs or at later stages of DSBs repair leading to a switch from ATM to ATR at the site of the 
damage 80. 
ATM and ATR are serine/threonine protein kinases able to recruit other DDR factors to the 
site of damage through a phosphorylation-dependent process. One of the most important 
features of this process is the phosphorylation of the histone H2AX (γ-H2AX) that leads to 
the propagation of the signal over several megabases around DSBs and starts a cascade of 
factors assembly 81,82.  
During HR, the MRN complex is important for the stabilization of the DNA ends through the 
binding of the MRE11 subunit to DNA. This subunit has also exo- and endonuclease 
activities, which are fundamental for the DNA resection during the repair step 83. The second 
subunit of the complex is RAD50 that belongs to the SMC (Structure Maintenance of 
Chromosomes) family and contains ATPase domains that interact with both MRE11 and the 
DNA ends at the site of the damage 83. NBS1 does not possess a known enzymatic activity 
itself but participates in the DDR by mediating protein-protein interactions at the site of the 
DSBs and in particular associates with ATM via its C-terminal region 83,84. 
In case of HR activation, the MRN complex promotes the activation of the ATM kinase 
leading to DNA resection, through CtlP and BRCA1 and formation of single strand DNA 
(ssDNA). Formation of ssDNA is crucial for the switch from ATM to ATR, which recruits 
RAD51 and BRCA2 that are important for the correct alignment of the sister chromatids. At 
this point the Replication Protein A (RPA 1) can sense the ssDNA and start the formation of 
the Holliday Junction (HJ) together with BRCA2 70.  
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During NHEJ repairing pathway the Artemis nuclease processes the breaks and the 
XRCC4/LIG4 carries on the ligation of the two broken filaments  70.   
Other important substrates activated by ATM and ATR are represented by the downstream 
effectors kinases CHK2 and CHK1 respectively, which can act on different substrates 
involved in cell cycle progression, apoptosis, and gene transcription 85. Like other DDR 
factors, CHK2 and CHK1 do not stay at the site of damage but are released and dispersed in 
the nucleus where can target the CDC25 family phosphatases, the tumor suppressors p53 and 
BRCA1 and the kinase Wee1 86-88. Modulation of these factors leads to cell cycle arrest either 
in G1 phase, through the activation of p53 and p21, or in G2 phase, via inactivation of the 
CDC25 phosphatases and activation of Wee1 kinase leading to inactivation of the cyclin-
dependent kinase CDC2 89.  
 
DDR upon CDT and Typhoid Toxin intoxication 
CDT-intoxicated cells show many similarities to the DNA DSBs response described above 
and resemble the effects of the DDR induced by IR, a well-known genotoxic stress, which 
can act as carcinogen 90,91as summarized in Figure 4.  
CDT-induced DNA damage leads to activation of the ATM kinase, phosphorylation of 
histone H2AX, re-localization of the DNA repair proteins, such as MRE11 and RAD50, to 
the site of the damage activation of the tumor suppressor p53 and its transcriptional target, the 
cyclin-dependent kinase inhibitor p21, inactivation of CDC25 phosphatases and accumulation 
of the inactive hyper-phosphorylated form of CDC2 91-97.  
Our group has further demonstrated that the DDR signal coordinated by the sensor kinase 
ATM is transduced from the nucleus to the cytoplasm via the translocation and 
dephosphorylation of the guanine exchange factor (GEF) NET1 that in turns activates the 
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small GTPase RHOA  98,99. RHOA activation can then lead to the promotion of two different 
pathways. The RHOA kinases ROCKI and ROCKII control the formation of the actin stress 
fibers, while the mitogen-activated protein kinase (MAPK) p38 promotes cell survival 99. To 
further characterize the effectors of the CDT-induced survival response, Guerra et al. 
screened a Saccharomyces cerevisiae deletion library and selected 78 deletion mutants with 
reduced growth rate following inducible expression of CdtB. Among the human horthologs 
identified, the flap-endonuclease 1 (FEN1) and the tumor susceptibility gene 101 (TSG101) 
were shown to regulate DNA repair and endocytosis, respectively, and also share common 
interacting partners with RHOA. Further studies demonstrated that FEN1 but not TSG101 is 
involved in cell survival, MAPK p38 phosphorylation, RHOA activation and actin stress 
fibers formation in response to DNA damage 100. 
 
Integrin activation in response to CDT-induced DNA damage 
In Paper I, we have further characterized the integration of the DDR response with the re-
organization of the actin cytoskeleton and activation of survival signals. Indeed, actin stress 
fibers are usually anchored at focal adhesion complexes that form upon engagement of 
integrins with components of the extracellular matrix (ECM) 101,102.  
Integrins are heterodimeric transmembrane receptors formed by the non-covalent association 
of α and β subunits, but unlike classical signaling receptors (e.g., receptor tyrosine kinases), 
they do not possess enzymatic activity. Integrins activation is rather related to their ability to 
assume different affinity states that can be regulated bidirectionally: “outside-in” signaling 
induced by the components of the ECM or “inside-out” signaling induced by intracellular 
events that lead to the binding of integrins activator molecules such as talin and kindlin to the 
integrins cytoplasmic domain of β subunits 103. 
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Generally integrins are involved in different dynamic cellular processes such as cell 
proliferation, differentiation, survival and prevention of anoikis 104. Many of these processes 
are de-regulated in tumor cells 105. Thus, based on the strong re-organization of the cellular 
cytoskeleton and the formation of RHOA-dependent actin stress fibers in cells exposed to 
CDT, we assessed whether exposure to bacterial genotoxins promotes integrin activation, and 
which are the biological consequences of this activation.  
Adhesion assays on intoxicated cells showed that time-dependent intoxication was associated 
with increased cell spreading and promotion of paxillin-positive FA (focal adhesion) after 
only 20 minutes of seeding on fibronectin-coated coverslips. Interestingly the same 
phenotype was observed also in cells infected with Salmonella Typhimurium strain MC71, 
expressing the typhoid toxin (MC71TT). This result suggests that the response observed is a 
general reaction to the bacterial genotoxins-induced DNA damage. FACS analysis and 
antibody function blocking experiments demonstrated that the enhanced adhesion properties 
induced by intoxication were mediated by activation of integrin β1 and α5. Moreover, the use 
of a specific inhibitor of the DNA damage sensor kinase ATM, demonstrated that the 
integrin-mediated cells adhesion was coordinated by this DNA damage sensor kinase , and it 
is part of the classical response to agents that induced DNA DSBs, since it was also observed 
in irradiated cells (Paper I). 
As mentioned above one of the key factors that leads to stress fibers formation and 
rearrangement of the actin cytoskeleton, upon CDT-induced DNA damage, is the GEF 
protein NET1 99. In Paper I, we demonstrated that knocking down expression of the 
endogenous NET1 protein drastically decreased the spreading capacity of intoxicated cells 
upon seeding on fribronectin-coated coverslips. Nevertheless, the activation level of integrin 
β1 did not change, suggesting that that this effector regulates events downstream of the 
interaction of the integrin β1 with the ECM. 
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Fig. 4: Summary of CDT internalization pathway, DNA damagae response upon intoxication and 
inside-out integrins activation. 
As of today there are many examples of inside-out integrin signaling pathways and most of 
them are related to the cross-talk with membrane bound growth factor receptors or cytokine 
receptors. Members of the epidermal growth factor (EGF) receptor family, such as EGFR and 
ERBB2, may contribute to tumor and metastasis progression in different types of tumors, 
including breast and pancreatic cancers. High levels of ERBB2 in breast cancer patients can 
induce spontaneous mammary tumour formation and tumour cell invasion in cooperation 
with integrin α6β4 106.  
In pancreatic cancer, EGF stimulates metastasis in vivo through the activation of the integrin 
αvβ5. The EGF receptor (EGFR) activation induces a Src-dependent phosphorylation of p130 
CAS leading to activation of Rap1, a small GTPase involved in αvβ5 integrin activation 107. 
  25 
The stimulation of the chemokine receptor CXCR4 by its ligand, the cell-derived factor 1 
(SDF-1), increases the expression of integrins, such as α5β1 and αvβ3 and metastasis 
progression 108,109.  
In our study we have demonstrated that the inside-out activation of the integrin β1 can also 
start in response to nuclear events such as DNA damage.  
A very important aspect in integrins regulation is their recycling and trafficking from and to 
the plasma membrane. Integrins can either be endocytosed and recycled back to the cell 
membrane or transported via the ESCRTs (Endosomal Sorting Complex Required for 
Transport) to the multivesicluar body (MVBs), for further trafficking to the lysosome 110. In 
our work we show that knock down of the ESCTR components ALIX and TSG101, leads to 
an inhibition of cell spreading on fibronectin coated coverslips. 
To understand the biological significance of this novel DDR-dependent inside-out mode of 
integrin activation, we assessed whether it was associated with cell survival. The rational of 
this choice was the previous data obtained in our laboratory and demonstrating an important 
role of the RHOA-NET1 axis in promoting survival of intoxicated cells 100. 
Inhibition of integrin activation-dependent signaling by siRNA-mediated knock down of 
TSG101 and ALIX expression increased the mortality rate of CDT-intoxicated cells when 
adhesion was prevented by seeding the cells onto wells pre-coated with 1% agarose. Since 
TSG101 does not influence the adhesion-dependent cell survival 100, integrin activation may 
play a role specifically on the regulation of cell survival in absence of adhesion. 
Our work is in line with previous observation demonstrating that different doses of radiation 
induce enhanced cell adhesion in a variety of normal and transformed human cell lines 
resulting in a dose-dependent upregulation of β1, β3 and α5 integrins 111-114. However, we did 
not detect a general up-regulation of the surface expression of integrin β1, but rather an 
increased affinity for the ECM (Paper I), suggesting that there may be multiple mechanisms 
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that regulate integrin signaling, which may differ depending on the cell type or stages of cell 
differentiation. 
 
Integrins, metastasis and drug resistance 
In the context of the exposure to a potentially carcinogenic agents such as DNA damaging 
CDTs, activation of the integrin signaling may have important implications for metastatic 
disease and drug resistance. 
Metastasis is a multistep process that requires a regulation of several cellular processes such 
as cell attachment/detachment, epithelial to mesenchymal transformation, cell survival, cell 
migration and invasion, etc.. These processes are regulated by several adhesion molecules 
and growth factors, and integrins represent a crucial player in the initiation and progression of 
metastasis 115. In order to colonize distant organs, cancer cells must be able to detach from the 
primary tumor, get access to the blood vessels and survive within the blood stream. An 
example is the activation of the αvβ3 integrins in human breast cancer cells, which induce 
tumor cell arrest during blood flow through interaction with platelets and leukocytes leading 
to cell survival 116. Besides their role in the metastatic process, integrins can promote higher 
resistance to ionizing radiation and cytotoxic drugs. These phenomena are known as Cell 
Adhesion Mediated Drug Resistance (CAM-DR) and Cell Adhesion Mediated 
Radioresistance (CAM-RR) 112,113. It has been shown that interaction between cells and the 
ECM promoted radiation-induced G1 or G2 cell cycle arrest giving to the cells time to repair 
the DNA and not undergoing apoptosis 117,118.  
Integrins promoting cell survival effects have been observed also in response to 
chemotherapies drugs through the activation of antiapoptotic pathways mediated by p42/p44 
MAPK and p38 MAPK 119.  
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Our data contribute not only to understand better the effects of infections with genotoxin 
producing bacteria, but also to find new insights in the contest of integrins-induced cell 
survival upon genotoxic injuries.  
 
So far I have been describing what are the pathways and the most important factors activated 
in response to acute intoxication with CDTs. In the next chapters I will illustrate what are the 
consequences of chronic toxin exposure in an in vitro and in vivo models.  
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3 GENOMIC INSTABILITY 
 
Chronic activation of DNA damage response, promotion of survival signals and inhibition of 
apoptosis are only the starting points for cancer development. In order to acquire a malignant 
phenotype, cells have to accumulate several mutations, which give them the capacity to get 
growth, survival, or metastasis advantage. This process is called genomic instability (GI) and 
represents one of the enabling characteristic of cancer 44.  
GI has been found to be common to the majority of human cancers but it is still unknown 
when it starts and what is the molecular basis controlling it. Different forms of GI have been 
observed in cancers but the most common is the chromosomal instability (CIN), in which 
there is a change in the number or conformation of chromosomes 120. Other types of GI have 
been described such as the microsatellite instability (MSI), which is characterized by the 
expansion or contraction of repeating units present in microsatellite sequences and forms of 
genomic instability that are characterized by increased frequencies of base-pair mutations 121-
123. 
 
Mutation of DNA repair genes 
All these types of GI have been observed in hereditary cancers and linked to mutations in 
DNA repair genes. One example is represented by the hereditary non-polyposis colon cancer 
(HNPCC or Lynch syndrome) caused by a mutation in the DNA mismatch repair protein 
MSH2 gene leading to MSI 121. Germline mutations in the MYH gene, which is implicated in 
the DNA base excision repair (BER), are also associated with colorectal tumors 123. Other 
hereditary cancers such as breast and ovarian cancer, leukemia and lymphomas are associated 
with the presence of CIN and mutations within DNA repair genes such as BRCA1, BRCA2, 
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RAD50, NBS1, Werner syndrome and Bloom syndrome helicases (WRN and BLM), RecQ 
protein-like 4 (RECQL4) and Fanconi anemia genes 124-126.  
 
GI and oncogenes activation 
Deregulation of oncogenes and tumor suppressors is also strongly related to GI.  
It has been observed that in precancerous lesions there is a strong activation of the DNA 
damage response to DSBs evidenced an ATM-dependent phosphorylation of the histone 
H2AX, CHK2 and p53, and the presence of p53 binding protein 1 (53BP1) foci 127,128. 
Evidences of the presence of DSBs has been observed also in cancer lesions but in this case 
the DNA damage checkpoint pathway was compromised mostly due to mutations in the 
TP53 gene, which encodes the tumor suppressor p53 127,128. These data suggest that before the 
establishment of TP53 mutations, genomic instability is already present in precancerous 
lesions caused by induction of DNA DSBs. Interestingly one of the most evident differences 
between precancerous lesions and normal tissues is the presence of constitutive activated 
oncogenes, which are able to induce DNA DSBs, DDR and genomic instability by increasing 
DNA replication stress. 128-131.  
Replication stress is defined as slowing or stalling in replication fork progression and it can 
be caused but different sources: depletion of nucleotides, DNA lesions, collisions between 
replication and transcription complexes, etc…132. 
Overexpression or constitutive activation of oncogenes such as c-MYC and HRAS can lead 
to increasing of replication initiation or origin firing, which in turns can result in depletion of 
nucleotides and/or increasing of collisions between replication and transcription complexes 
133,134. Oncogene-induced stalling in replication fork might lead to the collapse of the stalled 
fork, which can cause DNA DSBs and genomic instability 135,136. 
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Activation of tumorigenic barriers 
To protect themselves from de-regulated proliferation due to the occurrence of GI or other 
pro-carcinogenic events, cells have evolved different defense mechanisms. Permanent cell-
cycle arrest (senescence) and apoptosis are defined as tumorigenic barriers and represent the 
most powerful defense against uncontrolled cell proliferation. Cells that undergo senescence 
are in a state of irreversible cell-cycle arrest and show activation of typical senescence 
markers like β-galactosidase both in vitro and in vivo 137. On the other hand apoptosis leads to 
a programmed cell death, which is characterized by cytochrome-c release and caspases 
activation 138. In the context of activation of tumorigenic barriers, the transcription factor p53 
represents a master regulator.  This protein coordinates the activation of senescence and 
apoptosis in response to several cellular stress such as DNA damage, hypoxia and nutrient 
deprivation 139,140. Although p53 is able to mediate both senescence and apoptosis in normal 
cells, it is still unknown which are the mechanisms that lead to one pathway or another 141.  
 
ROS as a trigger for genomic instability 
As mentioned in the first chapter of this thesis ROS production might represent another 
source of GI. Oxidative stress can cause DNA damage detected by the presence of 8-oxo-2’-
deoxyguanosine (8-oxodG), which represents the main product of DNA oxidation 142. This 
oxidative DNA lesion can lead to site-specific mutagenesis and G to T or A to C 
transversions, which have been found in different types of tumors carrying mutated 
oncogenes or tumor suppressor genes 143,144.  
Malignant transformation due to ROS has been observed in different in vitro and in vivo 
models 145-147. It has been shown that C3H/10T1/2 mouse fibroblast exposed to human 
neutrophils or hydrogen peroxide undergo malignant transformation. Cells injected right after 
treatment in nude mice gave rise to malignant and benign tumors formation 145.  
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ROS play also an important role in inflammatory conditions that precede cancer like in 
patients with chronic hepatitis or H. pylori-induced gastritis 148-150. 
Drake and colleagues have shown that patients with H. pylori-induced gastritis have a high 
level of ROS in the stomach, which decreased with the eradication of the bacterium 149. 
Moreover H. pylori-positive patients show a higher level of oxidative DNA damage in gastric 
mucosal samples compare to healthy volunteers 151.  
Further studies performed in BigBlue® mice have shown that after 6 months of H. pylori 
infection, the gastric mutation frequency was 1.7-fold higher than in uninfected mice 152. 
Mutations were mainly transversions and so associated to oxidative DNA damage, which is 
in line with increase in the iNOS (Inducible nitric oxide synthase) messenger RNA 
expression 152.  
 
CDT and genomic instability 
These data bring us to the following question: Is the role of bacteria infection in promotion of 
genomic instability limited only to chronic production of ROS, or could bacterial genotoxin 
contribute directly this process? To address this issue, we investigated on the effects of 
chronic exposure to sublethal doses of CDT in eukaryotic cells (Paper II).  
Rat fibroblasts and human colon epithelial cells (HCT116) have been exposed to sub-lethal 
doses of CDT for a long period of time and followed to monitor the occurrence of genomic 
instability and tumor progression. The sub-lethal dose of CDT is referred to the amount of 
toxin that does not induce an acute cell cycle arrest but it is still able to cause DNA damage. 
As a control, cells were treated with a mutated version of CDT unable to induce DNA 
damage. A total of 14 sublines were selected after 220 days in presence of CDT in two 
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independent experiments. Seven sublines, exposed to the mutant toxin for the same period of 
time, were used as negative control. 
After the treatment most of the selected sublines showed an increased mutation frequency, 
accumulation of chromosomal aberrations and enhanced anchorage-independent growth. A 
similar effect was described by Cuevas-Ramos and colleagues in 2010 when they performed 
a short-term infection of mammalian cells with E. coli strains producing colibactin 68. The 
authors showed that short-term exposure of the hamster CHO cell line to a low infection dose 
of pks positive E. coli, induced DNA damage response followed by cell division with signs of 
incomplete DNA repair. Consequently anaphase bridges, chromosome aberrations, ring 
chromosomes, translocations and aneuploidy were observed in infected cells 72h post-
infection. These aberrations persisted in dividing cells up to 21 days after infection and 
treated cells showed an increased rate of mutation frequency and capacity of growing in an 
anchorage-independent manner 68.  
These data suggest that pks positive E. coli could play an important role in the promotion of 
colon cancer formation by continuously provoking DNA damage at the enterocytes level. 
However our study showed that a substantial increase in the frequency of mutations and 
significant changes in chromosomal aberrations was observed only after 130 days and 60 
days of continuous exposure to CDT of the Big Blue fibroblasts and HCT116 cells, 
respectively. These data highlighted the fact that increasing of mutation frequency and the 
acquisition of a malignant phenotype require a long period of time and short-term 
experiments or co-cultivation with live bacteria might lead to under- or overestimation of the 
results.  
In order to verify whether the chronic intoxication with CDT affects the DNA damage 
response (DDR), these cells were left untreated, to be sure that the toxin effect could not 
interfere with the result, and then exposed to IR to test their response to DNA damage. All the 
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sublines, selected in the presence of the active toxin, showed a lower level of phosphorylated 
histone H2AX compare to the control, which were cells treated for the same period of time 
with a non-functional CDT. A quite high percentage of cells compare to the control were also 
able to continue cycling through the G1 phase after treatment with etoposide instead of 
arresting in G2 phase. Based on the findings published by Guerra et. al in 2008, we tested 
whether activation of MAPK p38 had a role also in the survival of chronic-intoxicated cells 
99. We demonstrated that the activation of the MAP kinase p38 signalling was much higher in 
the cells intoxicated with the functional CDT compare to the control, and selective inhibition 
of this kinase promoted a rapid cell death of the sublines selected in the presence of the active 
toxin. 
Interestingly we also observed that long-term exposure to CDT caused a twofold increase in 
the level of intracellular ROS compare to short-term intoxication or control cells.  
Taken together these results tell us that long-term exposure to CDT gives to the cells the 
ability to over come the tumorigenesis barrier, enhances the acquisition of a malignant 
phenotype and that production of ROS might have a synergistic effect on tumor progression. 
As mentioned before in this chapter, impairment of the DDR might represent a crucial point 
in the starting of the genomic instability process and accumulation of mutations. In Paper II 
we have demonstrated that chronic exposure to CDT resulted in impaired DNA damage 
response and DNA repair and this might play a very important role in the case of chronic 
infections with genotoxin-producing bacteria. 
Several in vivo models have studied the carcinogenic effect of bacterial genotoxins in vivo. 
The most compelling evidences are those reported by Arthur and colleagues. The authors 
have used an animal model of Inflammatory Bowel Disease (IBD) and colitis-associated 
CRC, and demonstrated the carcinogenic potential of colibactin. Treatment with the colon-
specific carcinogen azoxymethane (AOM) induced a higher incidence of invasive 
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adenocarcinoma in germ free IL 10 knock-out mice mono-colonized with a pks positive E. 
coli 153. Deletion of the pks genotoxic island reduced tumor multiplicity and invasion in 
Il10−/− mice treated with AOM, without altering intestinal inflammation 153. 
These observations were strengthen by the detection of pks positive E. coli in 66.7% and 40% 
of CRC and IBD patients respectively compared to 20% found in non-IBD/non-CRC 
controls, providing a stronger evidence of the association between the presence of pks+ 
bacteria, chronic intestinal inflammation and CRC 153. 
In vivo study on H. hepaticus long-term infection in A/JCr mice showed that both the 
isogenic mutant lacking CDT activity and the wild-type H. hepaticus induce chronic hepatitis 
at 4 and 6 months post-infection 154. However the mice infected with the mutant strain during 
a period of 10 months did not develop any hepatic dysplasic nodules while the animals 
infected with the toxigenic strain did 154. These data confirm that CDT has an important role 
in the induction of preneoplastic lesions in vivo. Nevertheless these results do not give 
information on the molecular changes that CDT promotes in order to lead to the acquisition 
of malignant phenotype such as type of genetic alterations and the factors involved in 
promotion of cell survival, which is what we have described in Paper II.  
  
A new in vivo model 
These evidences suggest that the presence of an active genotoxins in the context of a chronic 
infection may be carcinogenic. These data are extremely relevant in the context of S. Typhi: 
the only genotoxin producing bacterium that can establish a chronic asymptomatic infection 
and is associated with increased risk of cancer development in human subjects 3,155,156. 
Studying the role of the Typhoid Toxin in immunocompetent animal models represents a 
challenge, since S. Typhi is exclusively a human pathogen. To overcome this obstacle, we 
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have designed a model of S. Typhimurium expressing the Typhoid Toxin genes, which can 
promote a chronic infection in immune competent mice. Having developed this model, we 
can now ask two important questions: 
1. Is the chronic infection with the genotoxin producing S. Typhimurium pro-
carcinogenic?  
2. What is the role of this toxin in the context of Salmonella infection? 
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4 DEVELOPMENT OF A NEW MODEL TO STUDY THE 
CARCINOGENIC POTENTIAL OF GENOTOXINS IN VIVO 
 
Salmonella enterica 
The genus Salmonella consists of two species: Salmonella bongori, a commensal of cold-
blooded animals, and Salmonella enterica (divided into six subspecies) 157. Salmonella 
enterica subspecies can be classified on the basis of the O (lipopolysaccharide [LPS]) surface 
antigen into more than 50 serogroups and into over 2400 serotypes or serovars when strains 
are differentiated by both their O and H (flagellar) antigens 158. The majority of the serovars 
associated to human infections belong to S. enterica ssp. I, which are responsible for enteric 
or typhoid fever and colitis/diarrheal disease through the ingestion of contaminated food or 
water 159.  Typhoid fever, a severe systemic infection, is caused by the exclusively human 
pathogens S. enterica serovar Typhi and S. enterica serovar Paratyphi A and B. Colitis 
instead is a localized infection caused mainly by S. enterica serovar Typhimurium and 
serovar Enteritidis, which are able to infect a wide range of animal hosts besides humans 
160,161.  
In this chapter, I will discuss mainly about S. Typhi and S. Typhimurium infection strategies 
since these are the bacteria relevant for our studies.  
Upon ingestion of contaminated food or water the bacterium is able to survive the low pH of 
the stomach via the activation of the acid tolerance response, which helps to maintain the 
intracellular pH higher than the one of the extracellular environment 162. After reaching the 
ileum, a second barrier against Salmonella is represented by the mucus layer that protects the 
intestinal epithelium. However the bacterium can penetrate this layer using flagella and 
chemotactic movements 163. In mice, S. enterica seems to preferentially adhere to and invade 
the microfold (M) cells of the Peyer’s patches (PPs) in the intestinal epithelium via 
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pinocytosis, although active endocytosis in enterocytes can also occur 164. Right after 
adhesion, the invasion process starts with the induction of a significant rearrangement of the 
host cells cytoskeleton and consequent formation of membrane ruffles that engulf adherent 
bacteria into large vesicles called Salmonella-containing vacuoles (SCVs) 165-169. In the 
SCVs, Salmonella survives and replicates protected against eventual lysosomal degradation 
and exploiting cellular trafficking to access to nutrients 170-172. A fraction of SCVs 
transcytoses to the basolateral membrane and releases the internalized bacteria to the 
submucosa where they are pinocytosed by macrophages 159. Migration of infected 
macrophages can facilitate a systemic dissemination of bacteria through the bloodstream to 
other tissues such as spleen and liver 160,173.  
In order to induce a bacterial-mediated endocytosis and hijack cellular pathways, Salmonella 
needs to produce and deliver different effectors. The majority of the virulence factors genes 
are located within highly conserved Salmonella pathogenicity islands (SPIs) and the effectors 
proteins are delivered to the host mostly through the Type III Secretion System (T3SS). This 
organelle is a multi-subunit protein with a characteristic needle-like structure capable of 
injecting effectors directly from bacterial cytoplasm into the host cell cytosol 174. T3SS are 
found in several Gram-negative pathogens and have a key role in the contact-dependent 
translocation of substrate proteins into host cells 175. Salmonella encodes for two T3SS, called 
T3SS-1 and T3SS-2, located in two different SPIs: SPI-1 and SPI-2 respectively 176.  
Effectors proteins translocated via the T3SS-1 are involved in cytoskeleton reorganization, 
triggering invasion into non phagocytic cells, such as fibroblasts and epithelial cells, 
establishment of permissive intracellular niche and induction of expression of 
proinflammatory cytokines and chemokines 177-179.  
The T3SS-2 is expressed upon Salmonella internalization into the SCVs and SPI-2 effectors 
are involved in manipulating the vesicular trafficking in order to enhance intracellular 
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survival and establish systemic infection 180. Very important for the survival of Salmonella in 
the host cell is the production of Salmonella-induced filaments (SIFs). These tubular 
structures originate from the SCVs and aggregate along a scaffold of microtubules extending 
throughout the cell 181. Among the key factors in SIFs production, only SifA seems to be 
absolutely required and it has been shown that S. Typhimurium ΔsifA mutants are less 
virulent in mice and have a lower intracellular replication in cultured macrophages but not in 
epithelial cells as reported by Stein and colleagues 182,183. In order to start the SIFs production, 
the N terminus of SifA binds to a host protein called SifA kinesin interacting protein (SKIP), 
which connects the SCVs to microtubule motor kinesin 184,185. On the other hand the C 
terminus of SifA binds to members of the Rho small GTPase family and the two events 
together trigger the formation of SIFs 185.  
These findings indicate that the production of SIFs is important for the pathogen replication 
into the host cell.  
Since S. Typhi is restricted to humans, there are no suitable animal models to study the effect 
of typhoid fever pathogenesis. For many years S. Typhimurium has been used in a systemic 
infection model using susceptible mouse strains in which it reproduces many of the 
characteristics of the human typhoid fever 186 187. Mice susceptibility is due to a non-
functional natural-associated macrophage protein 1 (Nramp1) gene (Nramp-/-), which is 
important for the destabilization of the metabolic activity in the SCVs 188.  
On the other hand, the use of mouse strains carrying a functional Nramp gene (Nramp+/+) 
represents a good model to study the chronic infection observed in S. Typhi carriers 189. 
While BALB/c and C57BL/6 are Nramp-/- mice strains, the sv129 mice carry the wild type 
version of the Nramp1 gene and have been used by Monack and colleagues in order to study 
the mechanisms of persistent infection 189. In this study, mice were infected with 108 S. 
Typhimurium bacteria and tissue colonization, fecal shedding, and tissue pathology were 
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monitored along a period of twelve months. Although at the end of the experiment bacteria 
were still detectable in spleen, liver and gall bladder of only few mice, almost in all the 
animals the Salmonella persisted within macrophages in the mesenteric lymphnodes (MLNs) 
189.  
 
A novel Salmonella infection model 
Following the analysis of these data, we decided to use sv129 mice and chronically infect 
them with the S. Typhimurium fully virulent strain MC1 or the attenuated MC71 strain, 
which carries a single point mutation within the polynucleotide phosphorylase (PNPase) gene 
190. S. Typhimurium does not express the Typhoid Toxin, therefore the pltB–pltA and cdtB 
genes of S. Typhi were cloned into the chromosome of S. Typhimurium under the control of 
their endogenous promoters. The new toxigenic strains (MC1/MC71-TT) and the isogenic 
strains lacking for the cdtB gene (no toxigenic MC1/MC71-	  ΔcdtB) were used to infect sv129 
mice orally, the natural route of Salmonella infection (Paper III).  
The animals were randomized into three groups: one group was left uninfected, a second 
group was infected with MC1- or MC71-TT strain and the third group was infected with the 
control strain MC1- or MC71-	  ΔcdtB at the infectious dose of 108 bacteria per mouse, as 
reported by Monack and colleagues189 and summarized in Figure 5. As expected, 
approximately 40% of the mice infected with the control MC1- ΔcdtB strain died within the 
first 15 days post-infection (p.i.) 189.  
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Fig. 5: Infection model for the short- and long-term infection with MC1/M71 ΔCdtB and MC1/MC71 
TT strains 
Interestingly, we observed a reduced mortality rate in mice infected with the MC1-TT strain 
compare to the ones infected with the MC1- ΔcdtB strain. MC71-TT and MC71-	   ΔcdtB 
infected mice followed a similar trend although with a less pronounced effect. Mice that 
overcome this critical period of 15 days survived and did not present any obvious symptoms, 
independently of the strain used. The enhanced survival of mice infected with the toxigenic 
strain is not due to an impair ability of MC1-TT or MC71-TT to invade the host, since equal 
amount of bacteria was recovered in the MLNs, liver and spleen of all the mice 30 and 60 
p.i.. However, the presence of a functional toxin was associated with higher frequency of 
mice carrying S. enterica 180 days p.i. in liver, MLNs and cecum, indicating that it may 
contribute to the establishment of a chronic infection.  
To further investigate the effects of the TT on the host response, we performed histological 
and transcriptomic analysis at 60 days p.i. in mice infected with the MC1 and MC71 strains. 
Data showed that the presence of the Typhoid Toxin reduced tissue damage and the host 
inflammatory response in the intestine. On the other hand infection with the toxigenic strain 
enhanced signs of severe pathology and the levels of inflammation in the liver. The reduced 
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intestinal inflammation is reminiscent of the capacity of S. Typhi to exert a silent intestinal 
invasion, followed by systemic symptomatic spread 191. The presence of a bacterial genotoxin 
may suppress the host immune response like in the case of CDT, which is able to block the 
proliferation and induce apoptosis of T- and B-lymphocytes54,91.  
The anti- and pro-inflammatory effect observed in the intestine and in the liver, respectively, 
might be due to a different type of immune response compare to the intestine: activation and 
recruitment of suppressive regulatory T lymphocytes in the intestine versus a Th1/Th17 pro-
inflammatory response in the liver 192. 
 
Effects of the Typhoid Toxin on the microbiota 
Interesting data came also from the intestinal microbiota analysis performed on bacterial 
DNA extracted from stool samples collected from mice infected with MC71 strains. Toxin-
specific effects on the host response seemed to be associated with a pronounced and long-
lasting alteration of the intestinal microbiota. Phylogenetic analysis showed a significant 
increase of Proteobacteria, which is associated with non-alcoholic fatty acid liver disease, and 
may contribute to the hepatic inflammation observed in mice infected with the toxigenic 
strain 193. We also performed an analysis more focused on the family level that revealed a 
reduction of the butyrate producers Lachnospiraceae in particular in mice infected with the 
MC71-TT strain. Previous studies have demonstrated that butyrate can negatively influence 
both viability and virulence gene expression during Salmonella invasion 194. This suggests 
that the reduction of the Lachnospiraceae that we observed might represent an advantage for 
Salmonella infection and invasion, and may also explain why we detected the presence of the 
MC1 toxigenic strain in the cecum of infected mice at 30 and 180 days post-infection. 
Streptomycin pre-treated mice have been used as model in many studies because these 
animals have a much more efficient intestinal colonization with S. Typhimurium 195, due to 
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alteration of the microbiota composition and possibly the reduction of butyrate levels, 
allowing Salmonella invasion in the cecum 196,197. Although this suggests that intestinal 
colonization increased because of a lack of competition with the microbiota components, on 
the other hand does not give any prove regarding the mechanisms of interaction, the causes or 
the effects of the Salmonella interplay with the intestinal microbiota. In this context, 
gnotobiotic mice might represent a good model to study the complicated relationship between 
Salmonella and the normal microflora since the composition of their microbial community 
can be controlled. Winter and colleagues have used this model to demonstrate that ROS 
produced during Salmonella Typhimurium infection react with luminal thiosulfate to produce 
tetrathionate, which can then be used as respiratory electron acceptor by Salmonella. This 
mechanism provides Salmonella with a big advantage compare to the other bacterial 
components of the intestinal microbiota, which have problems to survive the changes resulted 
from the Salmonella-induced inflammatory response 198.  
In our study, we have used wild type immunocompetent mice, not pre-treated with any 
antibiotics and infected through the natural route of Salmonella infection (oral infection). 
These conditions gave us the possibility to look at the effects of Salmonella from a different 
prospective without altering the system, and may offer new tools to assess how the typhoid 
toxin alters the host-microbiota environment thus favoring Salmonella colonization of the 
cecum. 
 
In conclusion, we have developed a unique model in which we have tried to be as close as 
possible to a real Salmonella infection to study the effects of bacterial genotoxins in the 
context of acute and long-term infections. 
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5 TYPHOID TOXIN SECRETION AND DELIVERY 
 
In vivo experiments with a S. Typhimurium expressing the TT represent a very important tool 
to better understand the role of this toxin during Salmonella infection. In order to exert its 
effect on the target cells, the Typhoid Toxin has to be secreted from the producing bacterium 
and access the nuclear compartment.  
Haghjoo and colleagues demonstrated that the Typhoid Toxin activity and the expression of 
the active subunit CdtB require the internalization of the bacteria in the host cell 65. This data 
suggests that the toxin, in order to reach its target in the nucleus, has to cross the SCV 
membrane. Interestingly, none of the T3SSs are required for the delivery of CdtB 65. In 2008 
Spanó and colleagues proposed a mechanism by which the toxin is produced in the SCVs and 
secreted in a soluble form in the extracellular environment where they can target bystander 
cells 66. However, the mechanism(s) of secretion from the producing bacterium as well as the 
mode of exit from the SCV have not been characterized. We have addressed this issue in 
Paper IV. 
 
OMVs 
Several lines of evidence have demonstrated that bacterial toxins, including the genotoxic 
CDT are secreted via outer membrane vesicles (OMVs), vesicles produced and shed by 
Gram-negative bacteria. OMVs appear at the electron microscope as spherical objects with a 
diameter of 50-250 nm and a bilayer membrane 199.  
Electrophoresis analysis and activity assays have demonstrated that OMVs contain a high 
abundance of LPS and periplasmic proteins, while components of inner membrane and 
cytoplasmic components are lacking or highly depleted. These data suggest that OMVs are 
not the result of random budding or a bacterial lysis 200-202 201,202. The details of the OMVs 
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production are still unknown but in general these vesicles originate when the outer membrane 
(OM) bulges and encapsulates periplasmic components 203. Thus proteins loaded into OMVs 
have to cross the inner membrane and reach the periplasmic space. Periplasmic translocation 
occurs mainly through two mechanisms: Sec- or Tat-mediated translocation across the 
cytoplasmic membrane 204,205. The main difference between these two pathways is that the 
Sec system is responsible for the transport of newly synthesized proteins, while Tat system 
transports already folded proteins 206.  
It has been shown that the CdtB subunit of the Typhoid Toxin contains a sec-dependent 
secretion signal that delivers the protein in the periplasmic space 65. In Paper IV, 
bioinformatics analysis demonstrated the presence of a N-terminal signal peptide that would 
mediate a sec-dependent translocation into the periplasmic space, where the assembled 
Typhoid Toxin can be packed and released via OMVs. To prove this hypothesis, we took 
advantage of the MC71-TT strain, generated in our laboratory for the in vivo analysis. Since 
the toxin is produced only in the SCV, upon internalization in the host cells, we mimic this 
environment by growing the bacteria in minimal medium pH 5.8 207. OMVs produced in 
these conditions were purified by differential ultracentrifugation. Immuno-gold labelling 
followed by electron microscopy analysis showed that the secreted LPS positive vesicles 
contained the active subunit, which could be detected only when the vesicles were disrupted 
by sonication, indicating that the toxin is contained within the vesicles.  
 
TT-loaded OMVs deliver cytotoxicity to bystander cells 
The purified vesicles were able to transfer the genotoxic activity to bystander cells. Paracrine 
internalization of typhoid toxin-loaded OMVs by bystander cells was dependent on dynamin-
1, indicating that the vesicles were internalized by an active endocytosis process. 
Internalization has been previously demonstrated for OMVs carrying other bacterial protein 
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toxins such as the Heat Labile enterotoxin (LT) of the Enterotoxigenic E. coli (ETEC). The 
VacA-loaded OMVs of H. pylori also require endocytosis to deliver their content to cells 208-
210. Conversely, CDT-loaded OMVs from A. actinomycetemcomitans fuse with the 
cholesterol rich domains of the target cells and release the toxin cargo directly in the cytosol 
211.  Thus it may be possible that there are several pathways for OMVs internalization within 
the host cells, and it will be interesting to evaluate what regulate the choice between 
endocytosis and fusion with the plasma membrane. These data indicate that the field of 
OMVs internalization is still at its infancy and more research in needed to clarify all these 
relevant issues.  
The subsequent induction of DNA damage was blocked by treatment with brefeldin A 
(BFA), indicating that retrograde transport of the Typhoid Toxin through the Golgi complex 
is required, similarly to the soluble CDT 63. We could not detect co-localization of the labeled 
OMVs with fluorescent Golgi tracker, indicating that the toxin has been released from these 
vesicles at the level of the endosomal compartment(s) (unpublished observation). 
 
Salmonella Typhimurium infected cells secrete TT-loaded vesicles 
Our data show that the typhoid toxin is secreted in vesicles. However, Salmonella produces 
this effector only within the SCV once internalized into the host cell, indicating that the 
OMVs have to cross several membranes in order to access the nuclear compartment of the 
infected and bystander cells as summarized in Figure 6. To assess whether OMVs are 
released from the infected cells into the extracellular medium, we purified the extracellular 
vesicles by differential ultracentrifugation, followed by sucrose gradient fractionation.  
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Fig. 6: Proposed model for Typhoid Toxin secretion and delivery. 
Immuno-gold labeling using a specific antibody directed against the Salmonella LPS 
followed by electron microscopy analysis revealed that the infected cells released 
approximately 30% of LPS positive vesicles with an average diameter of 120 nm, 
comparable to that of a OMVs subset released from bacteria grown in MM5.8 medium. 
Bacteria defective for the sifA gene, which are not able to form an intact SCVs, could not 
induce the release of extracellular vesicles (EVs) carrying the genotoxic activity. Treatment 
with nocodazole or cytochalasin D, which interfere with microtubule and actin 
polymerization, reduced the release of toxin-loaded vesicles of approximately 50%. Taken 
together these data suggest that the release of EVs containing the Typhoid Toxin required an 
intact SCVs and relied on anterograde transport toward the cellular cortex on microtubule and 
actin tracks.  
Very little is known about OMVs released from infected cells but there are evidences of the 
presence of OMVs in the cytoplasm of Salmonella-infected cells 212,213. Our study contributes 
to better understand this mechanism but further investigation is needed and could give new 
and interesting insights in the context of intracellular bacteria infection strategies.  
Generally OMVs represent an excellent tool that bacteria can use to deliver different types of 
cargoes (membrane-bounds proteins, lipids, quorum-signaling molecules, toxins, etc…), 
which can reach distant targets protected by the vesicles and, if it is necessary, in high 
concentrations 214.  
An interesting question at this point is: are OMV produced also in vivo? 
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 Fiocca and colleagues have found VacA-loaded OMVs in biopsy specimens of H. pylori 
infected tissues similar in appearance and composition to H. pylori vesicles made in vitro 215. 
These data suggest that OMVs are produced also in vivo.  
In conclusion our work provide new insights on the mode of secretion and delivery of 
exotoxins by cells infected with intracellular bacteria.  
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6 CONCLUSIONS 
This thesis aimed to study different aspects of the bacterial genotoxins in order to better 
characterize the cellular responses induced upon intoxication and the role that they have 
during infection in vitro and in vivo. Our data cover a broad range of questions about CDT 
and Typhoid Toxin biology from acute and chronic intoxication, and from in vitro and in 
vivo.  
1. Acute CDT intoxication in vitro to study the effects on integrin activation and 
survival signals 
2. Chronic CDT intoxication in vitro to better characterize long-term consequences on 
molecular and phenotypic changes 
3. Chronic and acute infection with S. Typhimurium in vivo to assess the role of the 
Typhoid Toxin in a new murine model 
4. In vitro characterization of secretion and delivery pathways for the Typhoid Toxin 
 
We described a novel inside-out integrin signaling pathway, which contributes to increase 
cells spreading and survival after short-term exposure to CDT. Our long-term intoxication 
experiments highlighted the carcinogenic potential of CDT in vitro and led us to set up a 
new murine model to investigate if this was true also in vivo. We decided to infect normal 
immunocompetent mice through the natural route of Salmonella to be as close as possible 
to the reality and this set up gave us the possibility to find something completely 
unexpected. We did not observe signs of cancer development but we may have revealed 
the physiological role of this toxin in the context of bacterial infection. Now we can use 
different models such as knock out mice for p53 and ATM to assess the carcinogenic 
properties of the Typhoid Toxin. 
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The characterization of the Typhoid Toxin trafficking from the infected cells to the 
extracellular space and its internalization in bystander cells contributed to better 
understand how intracellular bacteria can deliver their effectors. It would be very 
interesting to study these pathways also in vivo and see if TT-loaded OMVs can be found 
also in organs not directly infected with Salmonella.  
Genotoxins-producing bacteria represent still a very open field in cancer research and 
many questions are still without an answer.  
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